Results of a preclinical study on Nutrition 21 Inc.’s (Purchase, NY) chromium histidinate ingredient suggest that the ingredient may benefit diabetes patients who are at risk of insulin-induced hypoglycemia.
Results of a preclinical study on Nutrition 21 Inc.’s (Purchase, NY) chromium histidinate ingredient suggest that the ingredient may benefit diabetes patients who are at risk of insulin-induced hypoglycemia.
Hypoglycemia is an indication of abnormally low blood sugar, which can be caused by an overdose of injected insulin. This condition poses a risk of damage to the human brain.
So researchers at Firat University found that rats fed chromium histidinate before a high-dose injection of insulin were significantly less likely to experience brain damage compared to an untreated group of rats injected with insulin.
“A reduction in the incidence and/or severity of insulin-induced hypoglycemia would have significant value to people with diabetes who use insulin on a daily basis,” said James Komorowski, vice president of R&D at Nutrition 21.
The study, entitled “Chromium histidinate reduces brain damage caused by insulin-induced hypoglycemia,” was presented last week at the Federation of American Societies for Experimental Biology’s annual meeting in Washington, DC.
Sirio Pharma launches line of ready-to-market organic gummies and softgels called PureOrganix
August 26th 2024The new line is made up of three gummies and one softgel that are formulated to meet stringent EU-Organic certification criteria, and target women’s health, metabolic health, and heart health.
Recent review states that pentadecanoic acid may support cellular stability for better longevity
June 25th 2024According to the paper’s author, Stephanie Venn-Watson, DVM, MPH, deficiency in pentadecanoic acid of ≤0.2% total circulating fatty acids increases the risk of ferroptosis, which a type of cell death cause by the peroxidation of fragile fatty acids in cell membranes that combines with iron thus increasing reactive oxygen species, and disabling mitochondria.
Sirio Pharma launches line of ready-to-market organic gummies and softgels called PureOrganix
August 26th 2024The new line is made up of three gummies and one softgel that are formulated to meet stringent EU-Organic certification criteria, and target women’s health, metabolic health, and heart health.
Recent review states that pentadecanoic acid may support cellular stability for better longevity
June 25th 2024According to the paper’s author, Stephanie Venn-Watson, DVM, MPH, deficiency in pentadecanoic acid of ≤0.2% total circulating fatty acids increases the risk of ferroptosis, which a type of cell death cause by the peroxidation of fragile fatty acids in cell membranes that combines with iron thus increasing reactive oxygen species, and disabling mitochondria.
2 Commerce Drive
Cranbury, NJ 08512